See every side of every news story
Published loading...Updated

Unicycive Therapeutics (UNCY) - OLC Shows Synergy With Alternative Potassium Binder - Channelchek

Summary by channelchek.com
Friday, February 21, 2025 Robert LeBoyer, Senior Vice President, Equity Research Analyst, Biotechnology, Noble Capital Markets, Inc. Refer to the full report for the price target, fundamental analysis, and rating. Pre-Clinical Study Shows Synergy With Tenapanor. Unicycive Therapeutics announced the results of an animal model study that tested its phosphate binder, OLC, or oxylanthanum carbonate, and tenapanor, a phosphate-control drug that works…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

channelchek.com broke the news in on Friday, February 21, 2025.
Sources are mostly out of (0)